Answers are grounded in this paper and cite their sources.
Fanconi anemia (FA) is an autosomal recessive disorder characterized by progressive pancytopaenia, a diverse assortment of congenital malformations, and a predisposition to the development of malignancies. The extensive clinical heterogeneity observed in FA is reflected in genetic heterogeneity; the existence of 4 complementation groups has been inferred from complementation analysis. FA is putatively characterized as a DNA repair disorder since cells derived from patients are hypersensitive to DNA cross-linking agents. Although the primary defects in FA are not known, biochemical evidence supports either a direct defect in the removal of DNA cross-links or a defect in the ability of cells to respond to oxidative stress resulting from the interaction with cross-linking agents. Confirmation of either hypothesis awaits the cloning of genes defective in FA; some of the strategies to this end are discussed.
No takes yet. Share an insight, caveat, or question.
Strathdee et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: